AXTA vs CBT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

AXTA

43.2
AI Score
VS
CBT Wins

CBT

62.8
AI Score

Investment Advisor Scores

AXTA

43score
Recommendation
HOLD

CBT

63score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric AXTA CBT Winner
Forward P/E 14.0647 10.6157 CBT
PEG Ratio 2.0369 1.0017 CBT
Revenue Growth 3.1% 6.4% CBT
Earnings Growth -18.0% -93.7% AXTA
Tradestie Score 43.2/100 62.8/100 CBT
Profit Margin 6.8% 5.2% AXTA
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY CBT

Relative Price Performance (Last 90 Days)

AXTA 1M: +14.3% · 3M: +24.3% CBT 1M: -4.4% · 3M: +8.7%

Current Technical Phase

AXTA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.1% over 20 days), RSI 54

RSI (14): 53.5 · Price: $36.20

CBT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.3 · Price: $85.19

Fundamentals Snapshot

Metric AXTA CBT
Market Cap
Forward P/E 12.7 12.2
Trailing P/E 21.8 23.9
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.3% 0.2%
Operating Margin 0.2% 0.1%
EPS 1.63 3.56
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, CBT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.